866-997-4948(US-Canada Toll Free)

Cardiac Pacemakers - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Published By :

Axis Research Mind

Published Date : Jun 2013

Category :

Biotechnology

No. of Pages : 476 Pages


Global Market Watch:

BRICSS Cardiac Pacemakers market value is expected to reach US$903 million by 2016, primarily supported by the product types - Implantable Pacemakersand External Pacemakers. China accounts for nearly 27.5% of the market share and India claims more than 22.3%. In terms of CAGR, China is the fastest growing region while India and South Korea are just behind. Among the product types, Implantable Pacemakers accounts more than half of the market value while External Pacemakers segment adds up to the remaining half.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:

The report ‘Cardiac Pacemaker Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations. The report primarily focuses on:

  • Emerging Market Trends
  • Advancements in the Technological Space
  • Market Demand of The Segments (By-Region)
  • Key Growth Areas and Market Size
  • Region-Wise Demand Factor
  • Key Competitors Edge
  • Investment Strategies
The analysis primarily deals with by type. Further, the subdivided categories include:

Cardiac Pacemaker Devices – By Type
a.Implantable Pacemakers
i.Single-Chamber Pacemakers
ii.Dual-Chamber Pacemakers
iii.Biventricular Pacemakers
b.External Pacemakers

The period considered for the cardiac pacemaker devices market analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil,Russia, India, China, South Korea and South Africa).

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. 

The report consists of 104 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
TABLE OF CONTENT

I. REPORT FOCUS
A. INTRODUCTION

CARDIOLOGY
KINDS OF CARDIAC CONDITIONS

A. BLOOD FLOW IN THE HEART

B. HEART MALFUNCTION
TYPES OF CARDIAC ARREST

C. MYOCARDIUM
DISORDERS OF MYOCARDIUM

D. PERICARDIUM

E. HEART VALVES
DISORDERS OF HEART VALVES

F. CONGENITAL HEART DEFECT
TYPES OF CONGENITAL HEART DEFECT

G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)

H. HEART FAILURE

B. CARDIOVASCULAR DEVICES
DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
TOOLS DEPLOYED IN CARDIOLOGY
DIAGNOSTIC TESTS AND PROCEDURES
CONCLUSION

C. CARDIAC PACEMAKERS
IMPLANTABLE PACEMAKERS
CARDIAC PACEMAKER BATTERIES STYLES

APPLICATIONS FOR PACEMAKERS
A. IMPLANTABLE PACEMAKERS
I. SINGLE-CHAMBER PACEMAKERS
II. DUAL-CHAMBER PACEMAKERS
III. BIVENTRICULAR PACEMAKER

B. EXTERNAL PACEMAKERS
INDICATIONS FOR A PACEMAKER OR AN ICD
BRADYCARDIA PACING BY ICDS

D. CARDIAC PACEMAKERS - TYPES - MARKET BRIEFING
CHINA
INDIA
BRAZIL
RUSSIA
SOUTH KOREA
SOUTH AFRICA

II. MARKET ANALYSIS
CARDIAC PACEMAKERS – BRICSS – INDUSTRY SNAPSHOT

A. CARDIAC PACEMAKERS - SEGMENTATION
CARDIAC PACEMAKERS - GLOBAL
CARDIAC PACEMAKERS - BRICSS

CARDIAC PACEMAKERS - BY TYPE
CARDIAC PACEMAKERS - BRICSS
IMPLANTABLE PACEMAKERS
EXTERNAL PACEMAKERS

B. GROWTH RATE ANALYSIS
BRICSS CARDIAC PACEMAKERS MARKET GROWTH RATES
BRICSS CARDIAC PACEMAKERS - TYPE - GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW
FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS

A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
CARDIAC RHYTHM MANAGEMENT DEVICES
CRM IN EUROPE

CARDIAC DEFIBRILLATORS
RAPID GROWTH IN DEFIBRILLATOR SALES

CARDIAC PACEMAKER DEVICES
THE DATA COLLECTION WORK

CARDIAC RESYNCHRONIZATION THERAPY (CRT)

CARDIAC MONITORING AND DIAGNOSTIC DEVICES
THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW

INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS
EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION

FFR IMPACT ON DES MARKET
MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET

CARDIAC CATHETERS
COMPETITIVE ANALYSIS

ELECTROPHYSIOLOGY CATHETERS (EP)
GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH

EP MAPPING
NEW AF ABLATION DEVICES SEEK APPROVAL

ATRIAL FIBRILLATION (AF)

INTRAVASCULAR ULTRASOUND (IVUS)
GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS

PERIPHERAL VASCULAR DEVICES
ARTERIOTOMY CLOSURE DEVICES
EMBOLIC PROTECTION DEVICES (EPD)
INFERIOR VENA CAVA (IVC) FILTERS
CONCLUSION

PERIPHERAL GUIDEWIRES
AV ACCESS THROMBECTOMY DEVICES

PROSTHETIC HEART VALVES
SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
MARKET CHALLENGES

B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
SIZE AND WEIGHT
POWER EFFICIENCY
PERFORMANCE SPECIFICATIONS
RISK MITIGATION AND RELIABILITY
EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES

C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
IMPACT OF CVD IN EUROPE
IMPACT ON NEW YORK STATE
ECONOMIC IMPACT OF CVD IN NYS
HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
IMPACT OF CVD ON ECONOMIC STABILITY

ECONOMIC COST OF CARDIOVASCULAR DISEASES

COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030

CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE

D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND

E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES

F. MARKET TRENDS
PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL 
CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART\'S NATURAL REPAIR SYSTEMS
GE HEALTHCARE’S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
GE’S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
B. BRAUN\'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK’S NEW EVIA HF-T PACEMAKER.
AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN. 
MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
DRUG-ELUTING STENTS ARE SECURE
CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE\'S USER SATISFACTION SURVEY
ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.
HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”
BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY—INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
FIRST IMPLANT OF BOSTON SCIENTIFIC\'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
STUDY REVEALS THAT BAYER HEALTHCARE’S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)  
EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
ZOLL NOMINATED TO GLOBE 100 AGAIN
USCOM ENTERS EUROPEAN MARKETS
POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
USCOM SECURES STRONG PRESENCE IN US AND CANADA
CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
STENTYS’S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT 
CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
USCOM EYES EASTERN EUROPEAN MARKET
VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
INFECTIONS FROM IMPLANTED CARDIAC DEVICES
TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
HEART TRANSPLANTS SUBSTITUTED BY A PUMP
DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
REMOTE MONITORING OF HEART FAILURE PATIENTS
EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
OVER-THE-COUNTER APPARATUS
BOSTON SCIENTIFICS’ IMPLANTABLE DEFIBRILLATOR
CARDIAC SCIENCE’S NEW CARDIAC TREATMENT
THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
LOCAL MEDICARE’S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
BEST AND LATEST SELF-TEACHING HEART SOUNDS
REPLACING VALVE WITHOUT CARDIAC SUPPORT
U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS

G. KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES

CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS

CARDIAC MEDICAL DEVICES – PATENTS

KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX
RESEARCH FOCUS
ABOUT AXIS RESEARCH MIND
DISCLAIMER
FEEDBACK

List of Table


I. REPORT FOCUS
1. INDICATIONS FOR PERMANENT PACING WITH ACQUIRED ATRIOVENTRICULAR HEART BLOCK IN ADULTS

E. CARDIAC PACEMAKERS - TYPES - MARKET BRIEFING
CHINA
2. CARDIAC PACEMAKERS MARKET - TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS FOR CHINA - (2012-2018, IN USD$ MILLION)
3. CARDIAC PACEMAKERS TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS - % OF CHINESE MARKET VALUE - 
(2015 - 2018)

INDIA
4. CARDIAC PACEMAKERS MARKET - TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS FOR INDIA - (2012-2018, IN USD$ MILLION)
5. CARDIAC PACEMAKERS TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS - % OF INDIAN MARKET VALUE - 
(2015 - 2018)

BRAZIL
6. CARDIAC PACEMAKERS MARKET - TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS FOR BRAZIL - (2012-2018, IN USD$ MILLION)
7. CARDIAC PACEMAKERS TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS - % OF BRAZILIAN MARKET VALUE - (2015 - 2018)

RUSSIA
8. CARDIAC PACEMAKERS MARKET - TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS FOR RUSSIA - (2012-2018, IN USD$ MILLION)
9. CARDIAC PACEMAKERS TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS - % OF RUSSIAN MARKET VALUE - (2015 - 2018)

SOUTH KOREA
10. CARDIAC PACEMAKERS MARKET - TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS FOR SOUTH KOREA - (2012-2018, IN USD$ MILLION)
11. CARDIAC PACEMAKERS TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS - % OF SOUTH KOREAN MARKET VALUE - (2015 - 2018)

SOUTH AFRICA
12. CARDIAC PACEMAKERS MARKET - TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS FOR SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
13. CARDIAC PACEMAKERS TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS - % OF SOUTH AFRICAN - (2015 - 2018)

14. CARDIAC PACEMAKERS- PRODUCT BY BRANDS

II. MARKET ANALYSIS
15. BRICSS CARDIAC PACEMAKERS - SEGMENTATION BY TYPES

CARDIAC PACEMAKERS - GLOBAL
16. CARDIAC PACEMAKERS MARKET - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)

CARDIAC PACEMAKERS - BRICSS
17. CARDIAC PACEMAKERS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
18. CARDIAC PACEMAKERS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
19. CARDIAC PACEMAKERS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

CARDIAC PACEMAKERS - BY TYPE
20. CARDIAC PACEMAKERS MARKET - TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS FOR BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
21. CARDIAC PACEMAKERS - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS - % OF BRICSS MARKET VALUE - (2015-2018)

CARDIAC PACEMAKERS - BRICSS
IMPLANTABLE PACEMAKERS
22. IMPLANTABLE PACEMAKERS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
23. IMPLANTABLE PACEMAKERS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

EXTERNAL PACEMAKERS
24. EXTERNAL PACEMAKERS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
25. EXTERNAL PACEMAKERS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

B. GROWTH RATE ANALYSIS
BRICSS CARDIAC PACEMAKERSMARKET GROWTH RATES
26. CARDIAC PACEMAKERS MARKET - BRICSS- % GROWTH RATE FORECASTS - (2012-2018)

BRICSS CARDIAC PACEMAKERS - TYPES - GROWTH RATES
27. CARDIAC PACEMAKERS - TYPES - % GROWTH RATE FORECASTS FOR IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS - (2012-2018)

C. INVESTMENT FOCUS
28. CARDIAC PACEMAKERS - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
29. CARDIAC PACEMAKERS - TYPES - IMPLANTABLE PACEMAKERS AND EXTERNAL PACEMAKERS - FORECASTED CAGR% - VALUE - 2012 -2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL

III. INDUSTRY OVERVIEW
30. INTRAVENOUS DIAGNOSTICS - BY TYPE - FFR - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
31. INTRAVENOUS DIAGNOSTICS – BY TYPE - OCT - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
32. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2010, IN USD BILLION)
33. PROJECTED TOTAL COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2015-2030, IN USD BILLION)
34. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASE BY AGE - (2012, IN USD BILLION)
35. PROJECTIONS OF CRUDE CARDIOVASCULAR DISEASE PREVALENCE - (% - 2010-2030) IN THE UNITED STATES
36. PROJECTED DIRECT MEDICAL COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
37. PROJECTED INDIRECT LOST PRODUCTIVITY COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
38. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2014
39. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2013
40. WORLDWIDE KEY PLAYERS INTO CARDIOVASCULAR DEVICES INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
41. COVERAGE OF CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
42. CARDIAC ARRHYTHMIAS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
43. CIRCADIAN RHYTHM SLEEP DISORDERS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME - 2014
44. PERIPHERAL VASCULAR DISEASE (PVD) DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
45. ANNUAL SALES OF CARDIAC THERAPY PRODUCTS MARKETED BY THERAPY AREA - (2010-2012, IN US$ MILLION)
46. ABIOMED, INC. - PRODUCT REVENUE, FOR 2011-2013 (IN US$ \'000)
47. ACCELLENT, INC. - NET REVENUE, FOR 2011 AND 2012 (IN US$ \'000)
48. ALERE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ \'000)
49. AMBU A/S, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN DKK MILLION)
50. ANGIODYNAMICS, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ \'000)
51. ATRICURE, INC. - NET SALES BY PRODUCT IN DOMESTIC & INTERNATIONAL AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ \'000)
52. BAXTER INTERNATIONAL, INC. - NET SALES BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ MILLION)
53. BECTON, DICKINSON & CO - NET SALES BY MARKET SEGMENT, FOR 2011-2013 (IN USD$ MILLION)
54. BIOHEART, INC. - NET SALES, FOR 2011-2013 (IN US$ \'000)
55. BIOSENSORS INTERNATIONAL GROUP, LTD. - NET SALES REVENUE BY MARKET SEGMENT, LICENSING AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ \'000)
56. BIOTELEMETRY, INC. - NET SALES REVENUE AND GROSS PROFIT, FOR 2011-2013 (IN US$ \'000)
57. BOSTON SCIENTIFIC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN USD$ MILLION)
58. C. R. BARD, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
59. CARDICA, INC. - NET REVENUE, FOR 2011-2013 (IN US$ \'000)
60. COMPUMED. INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 IN USD
61. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT & GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
62. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT, FOR USA AND NON-USA FOR 2011-2013 (IN US$ MILLION)
63. CONMED CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ \'000)
64. CRYOLIFE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ \'000)
65. CRYOLIFE, INC. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ \'000)
66. DELTEX MEDICAL GROUP PLC - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ \'000)
67. DIGIRAD CORPORATION - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ \'000)
68. DRÄGER MEDICAL AG & CO. KG - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 (IN US$ \'MILLION)
69. EDWARDS LIFESCIENCES LLC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ \'MILLION)
70. ENDOLOGIX, INC, - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
71. HEARTWARE, LTD. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ \'000)
72. HOSPIRA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
73. INDRAPRASTHA APOLLO HOSPITAL - NET REVENUE, FOR 2012-2013 (IN INDIAN RUPEES)
74. INSPIREMD, LTD. - NET REVENUE, FOR 2012-2013 (IN US$ \'000)
75. JOHNSON & JOHNSON - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
76. KONINKLIJKE DSM N.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 IN (EURO MILLION)
77. LOMBARD MEDICAL TECHNOLOGIES PLC - NET REVENUE, FOR 2011-2013 (IN US$ \'000)
78. OPTO CIRCUITS (INDIA) LIMITED - NET REVENUE BY CONSOLIDATED AND STANDALONE, FOR 2011-2013 (IN INDIAN RUPEES)
79. MICROPORT MEDICAL (SHANGHAI) CO. LTD - NET REVENUE, FOR 2012 AND 2013 SIX MONTHS ENDED 30TH JUNE (IN RMB\'000)
80. ST. JUDE MEDICAL, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (US$ IN MILLION)
81. TTK - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN INDIAN RUPEES)
82. CARDIUM THERAPEUTICS, INC. - NET REVENUE, FOR 2012-2013 ENDED FOR NINE MONTHS (IN US$ MILLION)
83. MERIT MEDICAL SYSTEMS, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ \'000)
84. SPECTRANETICS INTERNATIONAL B.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ \'000)
85. VARIAN MEDICAL - NET REVENUE BY MARKET AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
86. TELEFLEX MEDICAL - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, FOR 2011-2013 (IN US$ MILLION)
87. ABBOTT VASCULAR DEVICES - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
88. MEDTRONIC, INC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2012 (IN US$ MILLION)
89. AORTECH INTERNATIONAL PLC - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ \'000)
90. VOLCANO CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ \'000)
91. PHILIPS MEDICAL SYSTEMS - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ \'000)
92. ATCOR MEDICAL HOLDINGS LIMITED - NET REVENUE BY GEOAGRAPHY, FOR 2012 AND 2013 (IN US$ MILLION)
93. LIDCO GROUP PLC - NET REVENUE BY PRODUCTS AND GEOGRAPHY, FOR 2011-2013 (IN GBP£ \'000)
94. SORIN GROUP USA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, 2011-2013 (IN EURO MILLION)
95. THORATEC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ \'000)
96. STEREOTAXIS, INC. - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2011 & 2012 (IN USD)
97. F.HOFFMANN-LA ROCHE LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN CHF MILLION)
98. PULSION MEDICAL SYSTEMS SE - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2012-2013 (IN EURO \'000)
99. NOVADAQ TECHNOLOGIES INC - NET REVENUE BY CATEGORY AND GEOGRAPHY, FOR 2011-2013 (IN USD)
100. SIEMENS MEDICAL SOLUTIONS USA, INC. - NET REVENUE BY GEOGRAPHY AND MARKET SEGMENT, FOR 2012 AND 2013 (IN € MILLION)
101. FUKUDA DENSHI CO. LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN MILLION YEN)
102. NIHON KOHDEN CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN MILLION YEN)
103. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 AND 2012 (IN YUAN)
104. ASAHI KASEI CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN ‘Y’ YEN)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *